For instance, MET function as the target of miR‐206 in suppressing lung cancer progression.27 Moreover, Ren et al. showed that miR‐206 showed suppression effect on colorectal cancer via targeting FMNL2.28 Zhang et al. reported that SOX9 took part in NSCLC progression as the target of miR‐206.29 In this study, we determined G6PD as the target of miR‐206 in NSCLC. This evidence concerns the gene FMNL2 and non-small cell lung carcinoma.